{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:44:59Z","timestamp":1790624699457,"version":"4.1.0"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,8,31]]},"abstract":"<jats:p>The manuscript described SARS-Cov-2 genotyping by VOC-NGS, which presents an ideal balance of accuracy, rapidity, and cost for detecting and globally tracking VOCs and some VOI of SARS-CoV-2. A large number of clinical samples can be tested together. Rapid introduction of new mutations at a specific site of the spike protein necessitates efficient strain detection and identification to enable choice of treatment and the application of vaccination, as well as planning public health policy.<\/jats:p>","DOI":"10.1128\/spectrum.00736-22","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T13:01:05Z","timestamp":1656334865000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing"],"prefix":"10.1128","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-420X","authenticated-orcid":true,"given":"Abdelmajeed","family":"Nasereddin","sequence":"first","affiliation":[{"name":"Head of the Genomics Applications Laboratory, Core Research Facility, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Golan Berman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-4160","authenticated-orcid":true,"given":"Dana G.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oiknine-Djian","sequence":"additional","affiliation":[{"name":"Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheera","family":"Adar","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7"},{"key":"e_1_3_2_3_2","unstructured":"Anonymous. 2019. World Health Organization: statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https:\/\/www.who.int\/news\/item\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_4_2","unstructured":"Anonymous. 2022. Worldometer 2022. https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9070565"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.043"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00932-w"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060633"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247115"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.587269"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.815389"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015303"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118056"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.012"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27202-x"},{"key":"e_1_3_2_18_2","volume-title":"SARS-CoV-2 variant classifications and definitions.","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. 2021. SARS-CoV-2 variant classifications and definitions. Centers for Disease Control and Prevention, Atlanta, GA."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104869"},{"key":"e_1_3_2_20_2","unstructured":"Nextstrain. 2021. Genomic epidemiology of novel coronavirus\u2014global subsampling. https:\/\/nextstrain.org\/ncov\/gisaid\/global. Accessed 4 October 2021."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.025"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01270-4"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab104"},{"key":"e_1_3_2_24_2","unstructured":"Anonymous. 2021. US Food and Drug Administration: emergency use authorization (EUA) of bamlanivimab and etesevimab. https:\/\/www.fda.gov\/media\/145802\/download. Eli Lilly and Company Indianapolis IN."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.02.003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2021.06.007"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.672562"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_2_29_2","unstructured":"ARTIC Network. 2019. ARTIC Network 2019. ARTIC nanopore protocol for nCoV2019 novel coronavirus. https:\/\/github.com\/artic-network\/artic-ncov2019. Accessed 4 October 2021."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00839-5"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2231"},{"key":"e_1_3_2_32_2","unstructured":"Rettner R. Woman develops rare 'coinfection' with two coronavirus variants. https:\/\/www.livescience.com\/coronavirus-coinfection-alpha-beta-variants.html. Future US Inc New York NY."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2021.06.004"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky379"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty695"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.22.10881"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00736-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00736-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T14:04:37Z","timestamp":1661954677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00736-22"}},"subtitle":[],"editor":[{"given":"Michael","family":"Klutstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8,31]]}},"alternative-id":["10.1128\/spectrum.00736-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00736-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"2022-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00736-22"}}